Compare BIOA & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIOA | INMD |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | United States | Israel |
| Employees | 62 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 757.0M | 842.0M |
| IPO Year | N/A | 2018 |
| Metric | BIOA | INMD |
|---|---|---|
| Price | $16.85 | $13.96 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 5 |
| Target Price | ★ $51.50 | $17.33 |
| AVG Volume (30 Days) | 375.2K | ★ 633.3K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $720.93 | $1.74 |
| Revenue Next Year | N/A | $3.26 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.79 | $12.72 |
| 52 Week High | $24.00 | $16.74 |
| Indicator | BIOA | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 44.66 | 46.55 |
| Support Level | $15.59 | $13.87 |
| Resistance Level | $21.29 | $14.79 |
| Average True Range (ATR) | 1.31 | 0.28 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 25.48 | 40.26 |
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.